Evaluation of physico-mechanical properties of drug-excipients agglomerates obtained by crystallization

References

• Chelakara LV, Sushrut KK, Dhanashri RK. Spherical agglomeration of mefenamic acid and nabumetone to improve micromeritics and solubility. AAPS. PharmSciTech. 2006;7(2):1–8.
   Web of Science ®Google Scholar
• Maghsoodi M, Hassan-zadeh D, Barzegar-jalali M, Nokhodchi A, Martin G. Improved compaction and packing properties of naproxen agglomerated crystals obtained by spherical crystallization technique. Drug Dev Ind Pharm. 2007;33:1216–1224.
   PubMed Web of Science ®Google Scholar
• Venkadarirammohan G, Sprinivas M, Madhobhai MP, Girish KJ. Spherical crystals of celecoxib to improve solubility, dissolution rate and micromeritic properties. Acta Pharm. 2007;57:173–184.
   PubMedGoogle Scholar
• Kawashima Y, Lin Y, Ogawa M, HanDA T, Takenaka H. Prolonged release microcapsules of indomethacin through spherical crystallization technique. J Pharm Sci. 1985;74:1152–1156.
   PubMed Web of Science ®Google Scholar
• Guillaume F, Guyothermann AM, Guyot JC. Spherical crystallization of meprobamate. Farmaco. 1993;48:473–485.
   Google Scholar
• Di Martino P, Barthelemy C, Piva F, Joiris E, Palmieri GE, Martelli S. Improved dissolution behavior of fenobufen by spherical crystallization. Drug Dev Ind Pharm. 1999;25: 1073–1081.
   PubMed Web of Science ®Google Scholar
• Kadam SS, Mahadik KR, Paradkar AR. A process for making agglomerates for use as or in a drug delivery system. Indian patent. 183036; 1997.
   Google Scholar
• Kadam SS, Mahandik KR, Paradkar AR. A process for making agglomerates for use as or in a drug delivery system. Indian patent. 183481; 1997.
   Google Scholar
• Maghsoodi M, Taghizadeh O, Martin G, Nokhodchi A. Particle design of naproxen-disintegrant agglomerates for direct compression by a crystallo-co-agglomeration technique. Int J Pharm. 2008;351:45–54.
   PubMed Web of Science ®Google Scholar
• Nokhodchi A, Maghsoodi M, Hassan-Zadeh D, Barzegar-Jalali M. Preparation of agglomerated crystals for improving flowability and compactibility of poorly flowable and compatible drugs and excipients. Powder Technol. 2007;175:73–81.
   Web of Science ®Google Scholar
• Pilpel N. The flow properties of magnesia. J Pharm Pharmacol. 1964;16:705–716.
   PubMed Web of Science ®Google Scholar
• Carr RL. Evaluation flow properties of solids. Chem Eng. 1965; 72:163–168.
   Google Scholar
• Carr RL. Classify flow properties of solids. Chem Eng. 1965; 72:69–72.
   Google Scholar
• Kawashima Y, Handa T, Takeuchi H, Okumara M, Katou H, Nagata O. Crystal modification of phenytoin with polyethylene glycol for improving mechanical strength, dissolution rate and bioavailability by spherical crystallization technique. Chem Pharm Bull. 1986;34:3376–3383.
   PubMed Web of Science ®Google Scholar
• Kawashima Y, Handa T, Takeuchi H, Okumura M. Effect of polyethylene glycol on size of agglomerated crystals of phenytoin prepared by the spherical crystallization technique. Chem Pharm Bull. 1986;34: 3403–3407.
   PubMed Web of Science ®Google Scholar
• Morishima K, Kawashima Y, Takeuchi H, Niwa T, Hino T. Micromeritic characteristics and agglomeration mechanisms in the spherical crystallization of bucillamine by the spherical agglomeration and the emulsion solvent diffusion methods. Powder Technol. 1993;76:57–64.
   Web of Science ®Google Scholar
• Paradkar AR, Pawar AP, Chordiya JK. Spherical crystallization of celecoxib. Drug Dev Ind Pharm. 2002;28:1213–1220.
   PubMed Web of Science ®Google Scholar
• Morishima K, Kawashima Y, Takeuchi H, Niwa T, Hino T. Spherical crystallization of celecoxib to improve solubility, dissolution rate and micromeritic properties. Acta Pharm. 2007:57:173–184.
   PubMedGoogle Scholar
• Sethia S, Squillante E. Physicochemical characterization of solid dispersions of carbamazepine formulated by supercritical carbon dioxide and conventional solvent evaporation method. J Pharm Sci. 2002;91:1984–1957.
   Web of Science ®Google Scholar
• Krahn FU, Mielck JB. Relations between several polymorphic forms and the dihydrate of carbamazepine. Pharm Acta Helv. 1987;62:248–254.
   Google Scholar
• Lowes MMJ, Caira MR, Lo”ter AP, Van Der Watt JG. Physico-chemical properties and X-ray structure studies of the trigonal polymorph of carbamazepine. J Pharm Sci. 1987;76:744–752.
   PubMed Web of Science ®Google Scholar
• Rustichelli C, Gamberini G, Ferioli V, Gamberini MC, Ficarra R, Tommasini S. Solid-state of polymorphic drug: Carbamazepine. J Pharm Biomed Anal. 2000;23:41–54.
   PubMed Web of Science ®Google Scholar
• Edwards AD, Shekunov BY, Kordikowski A, Forbes RT, York P. Crystallization of pure anhydrous polymorphs of carbamazepine by solution enhanced dispersion with supercritical fluids (SEDSe). J Pharm Sci. 2001;90:1115–1124.
   PubMed Web of Science ®Google Scholar
• Zhao N, Augsburger L. The influence of product brand-to-brand variability on superdisintegrant performance: A case study with croscarmellose sodium. Pharm Dev Technol. 2006;11:79–185.
   PubMed Web of Science ®Google Scholar
• Shah U, Augsburger L. Evaluation of the functional equivalence of crospovidone NF from different sources. II Standard performance test. Pharm Dev Technol. 2001;6:419–430.
   PubMed Web of Science ®Google Scholar
• Lopez-Solisa J, Villafuerte-Roblesa L. Effect of disintegrants with different hygroscopicity on dissolution of norfloxacin: Pharmatose DCL 11 tablets. Int J Pharm. 2001;216:127–135.
   PubMedGoogle Scholar
• Gordon MS, Chowhan ZT. Effect of tablet solubility and hygroscopicity on disintegrant efficiency in direct compression tablets intem of dissolution. J Pharm Sci. 1987;76:907–909.
   PubMed Web of Science ®Google Scholar
• Johnson JR, Wang LH, Gordon MS, Chowhan ZT. Effect of formulation solubility and hygroscopicity on desentegration efficiency in tablet prepared by wet granulation intem of dissolution. J Pharm Sci. 1991;80:469–471.
   PubMed Web of Science ®Google Scholar
• Jbiilou M, Ettabia A, Gguyot-Hermann AM, Guyot JC. Ibuprofen agglomerates preparation by phase sepration. Drug Dev Ind Pharm. 1999;25:297–305.
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Ito S, Itai S, Yamamoto K. Physicochemical properties and bioavailability of carbamazepine polymorphs and dehydrate. Int J Pharm. 2000;193:137–146.
   PubMed Web of Science ®Google Scholar
• Tian F, Sandler N, Aaltonen J, Lang C, Saville DJ, Gordon KC, Strachan CJ, Rantanen J, Rades T. Influence of polymorphic form, morphology, and excipient interactions on the dissolution of carbamazepine compacts. J Pharm Sci. 2007;96(3):584–594.
   PubMed Web of Science ®Google Scholar